New Key Statistics Module, Z-Score and F-Score
OTCPK:AMMCF Key Ratios
| Market Cap $ M | 4.06 |
| Enterprise Value $ M | 1.63 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.51 |
| Price/Sales | -- |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -1.08 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | 12.70 |
| 5-y EBITDA Growth Rate % | 13.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.75 |
| EV-to-EBITDA | -0.75 |
| PEG | -- |
| Shares Outstanding M | 32.68 |
| Net Margin (%) | 24,035.48 |
| Operating Margin % | 6,303.23 |
| Pre-tax Margin (%) | 5,661.29 |
| Quick Ratio | 6.56 |
| Current Ratio | 6.56 |
| ROA % (ttm) | -181.01 |
| ROE % (ttm) | -250.79 |
| ROIC % (ttm) | -564.20 |
| Dividend Yield % | -- |
| Altman Z-Score | -- |
AMMCF Number of Guru Trades
AMMCF Volume of Guru Trades
Gurus Latest Trades with OTCPK:AMMCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:AMMCF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Crism Therapeutics Corp Insider Transactions
No Available Data
News about OTCPK:AMMCF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers